Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Multiconsult to present its strategy and the nextLEVEL improvement programme at the Capital Markets Day

Multiconsult will today host its Capital Markets Day and will present an update on its strategic direction and introduce its 'nextLEVEL' profitability improvement programme, as well as new financial targets.Multiconsult is one of the leading firms of consulting engineers, architects and designers in Norway. With roots going back to 1908, the company has played an important role in Norway’s development and economic growth. With 3 000 highly skilled employees, the company is able to provide a full range of services including multidisciplinary consulting and design, project management,

INTERIM REPORT FOR THE THIRD QUARTER 2019 NEW WAVE GROUP AB

PERIOD 1 JULY – 30 SEPTEMBER 2019 · Net sales amounted to SEK 1,685.5 million, which was 9 % (5 % in local currencies) higher than last year (SEK 1,551.2 million). · Operating result amounted to SEK 129.1 (117.5) million. · Result for the period amounted to SEK 94.4 (88.4) million. · Earnings per share amounted to SEK 1.45 (1.36). · Cash flow from operating activities amounted to SEK -131.1 (-83.0) million. PERIOD 1 JANUARY – 30 SEPTEMBER 2019 · Net sales amounted to SEK 4,879.3 million, which was 12 % (7 % in local currencies) higher than last year (SEK 4,347.2

Photocure ASA: Results for the third quarter of 2019

Oslo, Norway, 7 November 2019: Photocure ASA (OSE:PHO), today reported a revenue growth of 42% in local currency for the U.S. market in the third quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 51.1 million (Q3 2018: NOK 43.5) and an EBITDA of NOK 8.3 million (NOK -3.1 million). The company entered into a license agreement with Asieris for the global commercialization of Cevira® and reiterates the significant revenue growth and profit opportunities in the U.S. market.“The third quarter was a busy period for Photocure with continued strong growth in the important U.S market

BERGENBIO ASA: Invitation to third quarter 2019 results presentation and webcast

Bergen, Norway, 7 November 2019 – BerGenBio ASA (OSE:BGBIO), will announce its results for the third quarter on Tuesday 19 November 2019. A presentation by BerGenBio’s senior management team will take place at 10am CET at: Arctic SecuritiesHaakon VIIs gate 5Oslo The presentation will webcast live and the link will be available at www.bergenbio.com in the section Investors/Financial Reports. A recording will be available shortly after the webcast has finished. The results report and presentation will be available at www.bergenbio.com in the section: Investors/Financial Reports

Multiconsult ASA third quarter 2019

Multiconsult third quarter 2019 net operating revenues were up 6.7% y-o-y to NOK 720.4 million. EBIT came in at NOK 21.0 million in the quarter and NOK 97.6 million YTD 2019. Third quarter result is impacted by net project write-downs of NOK 31.1 million. The order backlog remains strong at NOK 2.7 billion with a solid order intake of NOK 945 million in the quarter and NOK 3.0 billion year to date. Multiconsult initiates “nextLEVEL” profitability improvement programme, intensifying improvement efforts with a target of NOK 150 million annual improvements within 18 months.Oslo, 7 November

Lehto Group Plc: Business Review, January-September 2019

Lehto Group PlcStock exchange release7 November 2019 at 8.00 a.m.LEHTO GROUP PLC BUSINESS REVIEW, 1 JANUARY–30 SEPTEMBER 2019  January–September net sales down by 18.8%,operating loss EUR 41.9 million  This is not an interim report as specified in the IAS 34 standard. The company complies with half-yearly reporting according to the Finnish Securities Markets Act and discloses business reviews for the first three and nine month periods of the year, in which key information regarding the company's financial situation and development will be presented.   The financial

Targovax ASA: Third quarter 2019 results

Oslo, Norway, 7 November 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2019 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET (details below). HIGHLIGHTS FOR THE THIRD QUARTER 2019 · Targovax announced data from part 1 of the ONCOS-102 trial in checkpoint inhibitor refractory advanced melanoma, showing validated clinical responses in three out of nine patients (33% ORR), including one patient with a complete

Nel ASA: Third quarter 2019 results

(Oslo, November 7, 2019) Nel ASA (“Nel”) reported all-time high revenues of NOK 148.9 million (116.0) in the third quarter of 2019, in line with company outlook, and an order backlog of NOK 575 million. The order backlog grew 58%, compared to the end of the third quarter of 2018, and Nel reiterates the strong market outlook.   “Nel experienced another busy quarter with a 28% topline growth, in line with company outlook, and a high level of new business development activities. In addition, the Nel team continued to build the solid pipeline of tenders and projects across segments and

Webstep Q3 2019: Strengthening the platform for future growth

Oslo 7 November 2019: Webstep reports third quarter revenues in line with the same quarter last year and a weaker EBITDA margin. Capacity growth initiatives are starting to yield results with 5.3 per cent growth in headcount in the quarter. A revised strategy has been developed and measures to support future growth will be implemented going forward.Webstep ASA (“the Group” or “Webstep”) recorded consolidated revenues in the third quarter of NOK 137.2 million, down 0.6 per cent from the same quarter last year, affected by reduced headcount year-on-year, but offset by increased hourly rates

New genetic analysis improves diagnosis of intellectual disability

Whole-genome sequencing can be used to diagnose intellectual disability more accurately than other methods of genetic analysis, researchers at Karolinska Institutet report in the scientific journal Genome Medicine. Whole-genome sequencing using analytical tools developed by the researchers will now be introduced for first-line clinical diagnosis at Karolinska University Laboratory in Sweden.“Recent technical leaps in genetic diagnostics have revealed many new genetic aberrations that cause intellectual disability,” says Anna Lindstrand, associate professor at the Department of Molecular

World’s first Mobility-as-a-Service operator MaaS Global Completes €29.5M Funding Round

MaaS Global’s new investors include BP Ventures, Mitsui Fudosan, Mitsubishi Corporation and Nordic Ninja, raising the company’s total funding to €53.7M.Helsinki, Finland, 7 November 2019 – the World’s first Mobility-as-a-Service (MaaS) operator MaaS Global, known for its mobility application Whim, announced today that its most recent investment round is worth €29.5M ($32.7M), bringing the company’s total investments to €53.7M ($59.5). The new investors consist of BP Ventures, Mitsui Fudosan, Mitsubishi Corporation and Nordic Ninja. The earlier investors have also participated in the new

Webstep ASA: Long-Term Incentive Program – resolution to grant share options

Oslo, 6 November 2019: The Board of Directors in Webstep ASA (the Company) has in a meeting today, 6 November 2019, decided to allocate share options with reference to the power of attorney granted by the Annual General Meeting at 8 May 2019. The options will be granted 18 November 2019.The Board of Directors in Webstep ASA (the Company) has in a meeting today, 6 November 2019, decided to allocate share options with reference to the power of attorney granted by the Annual General Meeting at 8 May 2019. The options will be granted 18 November 2019, and the strike price of the share will be

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 06.11.2019

Fiskars Corporation  NOTIFICATION 06.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 06.11.2019 Date 06.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.8300 EUR  Highest price/share 11.8600 EUR Lowest price/share 11.7800 EUR Total price  11,830.00 EUR  The shares held by Fiskars Corporation on 06.11.2019: FSKRS 374,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

EAB GROUP PLC: ACQUISITION OF OWN SHARES 06.11.2019

EAB GROUP PLC  NOTIFICATION 06.11.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 06.11.2019 Date 06.11.2019Exchange transaction BuyShare class EABAmount 370Average price/share 2.8000 EUR  Highest price/share 2.8000 EUR Lowest price/share 2.8000 EUR Total price  1,036.00 EUR  The shares held by EAB Group Plc on 06.11.2019: EAB 1,903  On behalf of EAB Group Plc Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

United Bankers Corporation: Acquisition of Own Shares 06.11.2019

United Bankers Corporation NOTIFICATION 06.11.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 06.11.2019 Date 06.11.2019Exchange transaction BuyShare class UNIAVAmount 1,370Average price/share 8.7396 EURHighest price/share 8.9500 EURLowest price/share 8.6500 EURTotal price 11,973.25 EUR The shares held by United Bankers Corporation on 06.11.2019: UNIAV 34,019 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ) Antti Salakka

Communiqué from the extraordinary general meeting of Calmark Sweden AB (publ)

On Wednesday, 6 November 2019, Calmark Sweden AB (publ) held an extraordinary general meeting, chaired by Mathias Karlsson. The resolutions passed are summarized below. All resolutions were passed unanimously.Resolution to amend the Articles of AssociationThe extraordinary general meeting resolved, in accordance with the Board of Directors’ proposal, to amend the restrictions on the Company's share capital and number of shares in the Articles of Association according to the following: Clause 4 was resolved to be worded as follows:” The share capital shall be no less than SEK 1,250,

Veidekke ASA: Signs new major contract with Bane NOR

Today Veidekke signed yet another major contract with Bane NOR for the double track project Drammen-Kobbervikdalen on the Vestfoldbanen railway line. This time the contract involves building a culvert and a loose material tunnel, which is a design and build contract valued at NOK 1.83 billion excluding VAT.“We are both proud and pleased to have won this contract as well. Together with Bane NOR we have made a considerable effort to achieve good solutions for this challenging project. With good partners and our own expertise, we’re looking forward to starting this work,” says EVP Øivind

Toadman releases new trailer for IGI : Origins today

Toadman Interactive AB (publ) (“Toadman”) has today at 5 pm CET released a trailer for IGI : Origins (previously called Project I.G.I. 3), which is a game that Toadman fully owns. IGI : Origins is a sequel to the agent game released in the early 2000’s that has been played by millions of gamers globally. The trailer is the first larger project that shows the effect of the collaboration between Toadman and its newly acquired subsidiaries. Toadman has initiated similar marketing initiatives for all Toadman’s own games and the result of that work will continuously be presented. To watch

Power production in October 26.2 GWh

Weeker winds than normal in October resulted in a power production of 26.2 GWh, compared to the month’s budget of 33.3 GWh.   Halmstad 6 November, 2019 ARISE AB (publ)   For further information, please contact Daniel Johansson, CEO Arise AB, +46 702 244 133   This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.50 CET on 6 November, 2019.  Regarding information about how we process your personal

Commercial Genetic Testing: Well Known But Rarely Used

Consumers have a superficial understanding of direct-to-consumer (DTC) genetic testing products. However, prices, privacy concerns, and a lack of transparency make them less attractive to many potential customers. In a new study* by Simon-Kucher & Partners, end users were asked about their perceptions and knowledge of over-the-counter genetic tests.Cologne, November 6, 2019 – While 86 percent of study participants have heard of DTC genetic tests, only about five percent have purchased a kit themselves. The study examined four types of DNA self-tests. In addition to ancestry reports,

#19-1123 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

19-1122 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Selvaag Bolig ASA: Invitation to presentation of third quarter 2019 results

Selvaag Bolig ASA will publish its third quarter 2019 results Wednesday 13 November at 07:00 am CET. The quarterly report and the presentation materials will be available on the company's website, www.selvaagboligasa.no/en and www.newsweb.no, as well as news wires. CEO Rolf Thorsen and CFO Sverre Molvik will present the company's results at 08:30 am CET at Høyres Hus, Stortingsgaten 20 in Oslo. A light breakfast will be served from 08:00. The presentation will be held in Norwegian and transferred via live webcast. The link to the webcast can be found on the company's website. It

There are no items matching the current filter
There are no more items matching the current filter
Back to top